An experienced executive leader.
Arnoud Huisman, Consultancy and Management for Life Sciences. Many years of experience in leadership in a variety of positions. Strives towards a better life for everyone. His career as leader has developped naturally over the years.
As Managing Director and Chief Strategy Officer for Nuvisan Innovation Campus Berlin, Arnoud started the turn around of a 500 people Pharma discovery unit into a profit driven value chain for Pharma, Biotech and Venture Capital. With the $9.6mio contract with the Bill and Melinda Gates Foundation as tangible example of the success.
As CEO of CC Diagnostics, Arnoud secured funding to develop and market a superior diagnostic for early stages of cervical cancer.
Other roles have always been in area’s where science needs to be translated into commercial results, i.e. as the Chief Commercial Officer of Julius Clinical, a scientific research organisation that is able to combine the latest scientific insights with operational excellence to find credible, creative, cost-effective solutions for clinical trials.
Key assets.
- Strategic Deadlock that needs an external and Innovations Driven Approach.
- Disconnect between operations and business development that needs to be fixed / aligned.
- Scientific oriented organization that needs to be transformed into a client focussed and profitable business by combining science and commercial/business development.
About Arnoud.
An experienced executive leader with 30+ years in a variety of Life Science area’s (CRO, ARO, Pharmaceutical, Biotech, Venture Capital, Merger & Acquisition, Functional Food and Diagnostics). Key leadership roles in commercial, line, marketing, scientific and operational management for local and global companies, as well as EU and USA based M&A. Member of several Executive Steering Committees for large global and biotech companies in Europe and USA. Board position at Delphi Bioscience, ACRON, EUCROF, DCTF. Has secured over $2 billion in opportunities and investments. Direct P&L responsibility up to $150 million and 500 people.
Success is driven by focus, commitment, getting it done, organizational talent and an intrinsic motivation to increase people’s personal performance.
See the Values that create ValueMy portfolio.
What makes Science to Value the best option.
Managed several Phase I-IIa clinics in The Netherlands (including Clinical Operations, Project Management, Science, QA and Data Support, as well as ensuring GCP compliance) with succesfull delivery of appr. 250 phase I and IIa trials. P&L responsibility with record high EBITDA %. Leading role in several international mergers and acquisitions, including organizational integration. Consultancy and Management for Life Sciences, thats what Science to Value is all about.
Key: Clients first!
Motto: Making it happen and make it better every day.
Deliverable: From Science to Value.
Values that create Value
Clients first
Changing the perspective from inside out to outside in. Helping others to achieve there goals.
Strategic Vision to Achieve Goals
Seeing ahead to future possibilities and translating the them into decisive strategies.
Engaging & Inspiring
Creating a climate in which people are motivated to do their best and to achieve their objectives.
Discovery
Building the drug discovery & development value chain from Target Identification to Proof of Concept in Patients